NCT03421626 - Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML) | Biotech Hunter

Enrollment

266

Participants

Timeline

Start Date

November 8, 2017

Primary Completion Date

August 20, 2018

Study Completion Date

August 20, 2018

Conditions

Leukemia, Myelogenous, Chronic

Interventions

DEVICE

Xpert BCR-ABL Ultra

Semi-quantitation of BCR-ABL transcript in patients that have been previously diagnosed with CML

Trial Locations (7)

St. Mary's Medical Center, Huntington

United Hospital Center, Bridgeport

WJB Dorn VA Medical Center, Columbia

Broward Oncology Associates, Fort Lauderdale

Marshfield Clinic, Marshfield

St. Alphonsus Regional Medical Center, Boise

Fred Hutchinson Cancer Research Center, Seattle